Please provide your email address to receive an email when new articles are posted on . SelectION’s lead compound, si-544, was well tolerated up to the highest dose levels. 75% of patients saw disease ...
A team of University of Michigan researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity. Their results, ...
The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s determination that 79 challenged composition claims across three related patents were unpatentable but ...
WOODS CROSS, Utah--(BUSINESS WIRE)--Phoenix PharmaLabs, Inc. (https://www.phoenixpharmalabs.com), a private company developing potent, non-addictive treatments for pain and substance abuse disorders, ...
Asahi Kasei Pharma announced that it has strengthened its drug discovery pipeline through an exclusive global license agreement regarding novel lead compounds for a single target with Alchemedicine, a ...
A team of researchers has successfully modified a naturally occurring chemical compound in the lab, resulting in advanced lead compounds with anti-HIV activity. A team of University of Michigan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results